{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:18:38Z","timestamp":1792268318119,"version":"4.4.0"},"reference-count":255,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.neuint.2012.12.016","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T04:04:35Z","timestamp":1357272275000},"page":"803-819","source":"Crossref","is-referenced-by-count":284,"title":["Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"62","author":[{"given":"Juliet M.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bevan S.","family":"Main","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Crack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0005","doi-asserted-by":"crossref","first-page":"e16038","DOI":"10.1371\/journal.pone.0016038","article-title":"Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice","volume":"6","author":"Akundi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2012.12.016_b0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-4615-4685-6_10","article-title":"The role of microglia and astrocytes in CNS immune surveillance and immunopathology","volume":"468","author":"Aloisi","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"issue":"37","key":"10.1016\/j.neuint.2012.12.016_b0020","doi-asserted-by":"crossref","first-page":"14807","DOI":"10.1073\/pnas.0703219104","article-title":"DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase","volume":"104","author":"Andres-Mateos","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"50","key":"10.1016\/j.neuint.2012.12.016_b0015","doi-asserted-by":"crossref","first-page":"15846","DOI":"10.1523\/JNEUROSCI.4357-09.2009","article-title":"Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)","volume":"29","author":"Andres-Mateos","year":"2009","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.neuint.2012.12.016_b0030","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/humu.21582","article-title":"Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death","volume":"32","author":"Angeles","year":"2011","journal-title":"Hum. Mutat."},{"issue":"7\u20138","key":"10.1016\/j.neuint.2012.12.016_b0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00335-011-9330-x","article-title":"Parkinson\u2019s disease mouse models in translational research","volume":"22","author":"Antony","year":"2011","journal-title":"Mamm. Genome"},{"issue":"49","key":"10.1016\/j.neuint.2012.12.016_b0040","doi-asserted-by":"crossref","first-page":"51647","DOI":"10.1074\/jbc.M407328200","article-title":"Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1beta, and expression of caspase-11 in mice","volume":"279","author":"Arai","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.neuint.2012.12.016_b0045","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.intimp.2011.05.006","article-title":"Toll-like receptors are key players in neurodegeneration","volume":"11","author":"Arroyo","year":"2011","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ana.21049","article-title":"Pesticide exposure might be a strong risk factor for Parkinson\u2019s disease","volume":"63","author":"Baldereschi","year":"2008","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0055","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mds.870130205","article-title":"Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson\u2019s disease","volume":"13","author":"Banati","year":"1998","journal-title":"Mov. Disord."},{"issue":"Pt 2","key":"10.1016\/j.neuint.2012.12.016_b0060","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/brain\/awh054","article-title":"The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson\u2019s disease","volume":"127","author":"Bandopadhyay","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2012.12.016_b0065","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/cddis.2011.17","article-title":"IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson\u2019s disease","volume":"2","author":"Barcia","year":"2011","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b0075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.neuint.2012.12.016_b0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0079-6123(10)84006-3","article-title":"Modeling neuroinflammatory pathogenesis of Parkinson\u2019s disease","volume":"184","author":"Barnum","year":"2010","journal-title":"Prog. Brain Res."},{"issue":"16","key":"10.1016\/j.neuint.2012.12.016_b0085","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1073\/pnas.0500617102","article-title":"Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability","volume":"102","author":"Beilina","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0090","doi-asserted-by":"crossref","first-page":"e1376","DOI":"10.1371\/journal.pone.0001376","article-title":"Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons","volume":"3","author":"Benner","year":"2008","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b1360","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1056\/NEJM199601113340202","article-title":"Prevalence of parkinsonian signs and associated mortality in a community population of older people","volume":"334","author":"Bennett","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2012.12.016_b0095","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S1353-8020(11)70008-6","article-title":"Misfolded alpha-synuclein and Toll-like receptors: therapeutic targets for Parkinson\u2019s disease","volume":"18","author":"Beraud","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00401-001-0503-7","article-title":"CD14 expression by activated parenchymal microglia\/macrophages and infiltrating monocytes following human traumatic brain injury","volume":"103","author":"Beschorner","year":"2002","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.neuint.2012.12.016_b0105","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0110","doi-asserted-by":"crossref","first-page":"e39953","DOI":"10.1371\/journal.pone.0039953","article-title":"Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"7","author":"Bian","year":"2012","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.neuint.2012.12.016_b0115","doi-asserted-by":"crossref","first-page":"9572","DOI":"10.1073\/pnas.1106291108","article-title":"PTEN-inducible kinase 1 (PINK1)\/Park6 is indispensable for normal heart function","volume":"108","author":"Billia","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuint.2012.12.016_b0120","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/BF00343235","article-title":"The l-dihydroxyphenylalanine (L-DOPA) effect in Parkinson\u2019s syndrome in man: on the pathogenesis and treatment of Parkinson akinesis","volume":"203","author":"Birkmayer","year":"1962","journal-title":"Arch. Psychiatr. Nervenkr. Z. Gesamte. Neurol. Psychiatr."},{"issue":"5","key":"10.1016\/j.neuint.2012.12.016_b0125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ana.21019","article-title":"Localization of LRRK2 to membranous and vesicular structures in mammalian brain","volume":"60","author":"Biskup","year":"2006","journal-title":"Ann. Neurol."},{"issue":"Pt 5","key":"10.1016\/j.neuint.2012.12.016_b0130","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1042\/BST0351127","article-title":"Chronic microglial activation and progressive dopaminergic neurotoxicity","volume":"35","author":"Block","year":"2007","journal-title":"Biochem. Soc. Trans."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2012.12.016_b0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients","volume":"202","author":"Blum-Degen","year":"1995","journal-title":"Neurosci. Lett."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2012.12.016_b0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-3940(94)90684-X","article-title":"Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson\u2019s disease","volume":"172","author":"Boka","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2012.12.016_b0145","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1353-8020(11)70004-9","article-title":"Autosomal recessive parkinsonism","volume":"18","author":"Bonifati","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0150","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"4596","key":"10.1016\/j.neuint.2012.12.016_b0160","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/1801200a0","article-title":"3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists","volume":"180","author":"Carlsson","year":"1957","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0170","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1471-4159.2009.06425.x","article-title":"Inactivation of neuronal forebrain a receptors protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"111","author":"Carta","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2012.12.016_b0165","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.neuroscience.2011.07.046","article-title":"Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson\u2019s disease model","volume":"194","author":"Carta","year":"2011","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.neuint.2012.12.016_b0175","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.bcp.2011.01.003","article-title":"Evaluating the role of Toll-like receptors in diseases of the central nervous system","volume":"81","author":"Carty","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0180","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1471-4159.2006.03777.x","article-title":"Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline","volume":"97","author":"Casarejos","year":"2006","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.neuint.2012.12.016_b0185","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0190","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/glia.20770","article-title":"NOD2 plays an important role in the inflammatory responses of microglia and astrocytes to bacterial CNS pathogens","volume":"57","author":"Chauhan","year":"2009","journal-title":"Glia"},{"issue":"8","key":"10.1016\/j.neuint.2012.12.016_b0205","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease","volume":"60","author":"Chen","year":"2003","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0195","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20682","article-title":"Nonsteroidal antiinflammatory drug use and the risk for Parkinson\u2019s disease","volume":"58","author":"Chen","year":"2005","journal-title":"Ann. Neurol."},{"issue":"22","key":"10.1016\/j.neuint.2012.12.016_b0210","doi-asserted-by":"crossref","first-page":"21418","DOI":"10.1074\/jbc.M413955200","article-title":"Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/aje\/kwm260","article-title":"Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease","volume":"167","author":"Chen","year":"2008","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2007.08.006","article-title":"In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson\u2019s disease?","volume":"209","author":"Chesselet","year":"2008","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/10715762.2010.509398","article-title":"Nitrosylation and nitration of mitochondrial complex I in Parkinson\u2019s disease","volume":"45","author":"Chinta","year":"2011","journal-title":"Free Radic. Res."},{"issue":"5675","key":"10.1016\/j.neuint.2012.12.016_b0225","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.1093891","article-title":"S-nitrosylation of parkin regulates ubiquitination and compromises parkin\u2019s protective function","volume":"304","author":"Chung","year":"2004","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0230","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","article-title":"Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging","volume":"15","author":"Cicchetti","year":"2002","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0240","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2005.03.018","article-title":"Systemic exposure to paraquat and maneb models early Parkinson\u2019s disease in young adult rats","volume":"20","author":"Cicchetti","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.neuint.2012.12.016_b0235","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tips.2009.06.005","article-title":"Environmental toxins and Parkinson\u2019s disease: what have we learned from pesticide-induced animal models?","volume":"30","author":"Cicchetti","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0245","doi-asserted-by":"crossref","first-page":"117","DOI":"10.55782\/ane-2003-1461","article-title":"Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson\u2019s disease","volume":"63","author":"Ciesielska","year":"2003","journal-title":"Acta Neurobiol. Exp."},{"issue":"7","key":"10.1016\/j.neuint.2012.12.016_b0255","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/mds.20131","article-title":"Analysis of an early-onset Parkinson\u2019s disease cohort for DJ-1 mutations","volume":"19","author":"Clark","year":"2004","journal-title":"Mov. Disord."},{"issue":"7097","key":"10.1016\/j.neuint.2012.12.016_b0250","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.neuint.2012.12.016_b0260","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1523\/JNEUROSCI.5367-11.2012","article-title":"Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo","volume":"32","author":"Colla","year":"2012","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0265","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0306-4522(02)00030-1","article-title":"Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease","volume":"112","author":"Combrinck","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2012.12.016_b0270","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2000.tb06903.x","article-title":"Accelerated oligomerization by Parkinson\u2019s disease linked alpha-synuclein mutants","volume":"920","author":"Conway","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0275","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson\u2019s disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"R1","key":"10.1016\/j.neuint.2012.12.016_b1320","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1093\/hmg\/ddq167","article-title":"Parkinson\u2019s disease: insights from pathways","volume":"19","author":"Cookson","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.neuint.2012.12.016_b0285","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00702-010-0397-4","article-title":"Parkinson\u2019s disease-associated DJ-1 modulates innate immunity signaling in Caenorhabditis elegans","volume":"117","author":"Cornejo Castro","year":"2010","journal-title":"J. Neural. Transm."},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0290","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.parkreldis.2009.11.004","article-title":"Worldwide frequency of G2019S LRRK2 mutation in Parkinson\u2019s disease: a systematic review","volume":"16","author":"Correia Guedes","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"issue":"5134","key":"10.1016\/j.neuint.2012.12.016_b0295","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.neuint.2012.12.016_b0300","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.1128\/JVI.79.8.5174-5184.2005","article-title":"Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease","volume":"79","author":"Cunningham","year":"2005","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0305","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/neur.1996.0020","article-title":"Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson\u2019s disease mice model","volume":"5","author":"Czlonkowska","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuint.2012.12.016_b0310","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1326-4-34","article-title":"Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons","volume":"4","author":"Daher","year":"2009","journal-title":"Mol. Neurodegener."},{"issue":"12","key":"10.1016\/j.neuint.2012.12.016_b1365","doi-asserted-by":"crossref","first-page":"e1001195","DOI":"10.1371\/journal.pgen.1001195","article-title":"Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn\u2019s disease","volume":"6","author":"Danoy","year":"2010","journal-title":"PLoS Genet."},{"issue":"22","key":"10.1016\/j.neuint.2012.12.016_b0315","doi-asserted-by":"crossref","first-page":"14524","DOI":"10.1073\/pnas.172514599","article-title":"Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP","volume":"99","author":"Dauer","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2012.12.016_b0320","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/mds.22798","article-title":"The role of parkin in familial and sporadic Parkinson\u2019s disease","volume":"25","author":"Dawson","year":"2010","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.neuint.2012.12.016_b0325","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson\u2019s disease","volume":"66","author":"Dawson","year":"2010","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0330","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2012.12.016_b0335","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1477-5956-9-59","article-title":"Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson\u2019s disease","volume":"9","author":"Diedrich","year":"2011","journal-title":"Proteome Sci."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0340","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.1999.tb00721.x","article-title":"Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism","volume":"100","author":"Dobbs","year":"1999","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/neu.10094","article-title":"Overexpression of Parkinson\u2019s disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP","volume":"53","author":"Dong","year":"2002","journal-title":"J. Neurobiol."},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0350","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/01677063.2011.627072","article-title":"Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions","volume":"25","author":"Drolet","year":"2011","journal-title":"J. Neurogenet."},{"issue":"25","key":"10.1016\/j.neuint.2012.12.016_b0355","doi-asserted-by":"crossref","first-page":"14669","DOI":"10.1073\/pnas.251341998","article-title":"Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease","volume":"98","author":"Du","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0360","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10048-006-0077-6","article-title":"The medial and lateral substantia nigra in Parkinson\u2019s disease: mRNA profiles associated with higher brain tissue vulnerability","volume":"8","author":"Duke","year":"2007","journal-title":"Neurogenetics"},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0365","doi-asserted-by":"crossref","first-page":"e39132","DOI":"10.1371\/journal.pone.0039132","article-title":"The IkappaB kinase family phosphorylates the Parkinson\u2019s disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling","volume":"7","author":"Dzamko","year":"2012","journal-title":"PLoS One"},{"issue":"40","key":"10.1016\/j.neuint.2012.12.016_b0370","doi-asserted-by":"crossref","first-page":"35104","DOI":"10.1074\/jbc.M111.247965","article-title":"E46K human alpha-synuclein transgenic mice develop Lewy-like and tau pathology associated with age-dependent, detrimental motor impairment","volume":"286","author":"Emmer","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0375","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ana.410320616","article-title":"The oxidant stress hypothesis in Parkinson\u2019s disease: evidence supporting it","volume":"32","author":"Fahn","year":"1992","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.neuint.2012.12.016_b0380","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0028-3908(86)90205-4","article-title":"Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutathione in the extrapyramidal system of the mouse","volume":"25","author":"Ferraro","year":"1986","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b0385","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1525-1373.1999.d01-140.x","article-title":"Antioxidants, oxidative stress, and degenerative neurological disorders","volume":"222","author":"Floyd","year":"1999","journal-title":"Proc. Soc. Exp. Biol. Med."},{"issue":"43","key":"10.1016\/j.neuint.2012.12.016_b0390","doi-asserted-by":"crossref","first-page":"10825","DOI":"10.1523\/JNEUROSCI.3001-08.2008","article-title":"Parkin deficiency increases vulnerability to inflammation-related nigral degeneration","volume":"28","author":"Frank-Cannon","year":"2008","journal-title":"J. Neurosci."},{"issue":"13","key":"10.1016\/j.neuint.2012.12.016_b0405","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1096\/fj.03-0109fje","article-title":"Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson\u2019s disease","volume":"17","author":"Gao","year":"2003","journal-title":"FASEB J."},{"issue":"30","key":"10.1016\/j.neuint.2012.12.016_b0400","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","article-title":"Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration","volume":"28","author":"Gao","year":"2008","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0410","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1289\/ehp.1003013","article-title":"Neuroinflammation and alpha-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson\u2019s disease","volume":"119","author":"Gao","year":"2011","journal-title":"Environ. Health Perspect."},{"issue":"9","key":"10.1016\/j.neuint.2012.12.016_b0415","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","article-title":"LRRK2 is involved in the IFN-gamma response and host response to pathogens","volume":"185","author":"Gardet","year":"2010","journal-title":"J. Immunol."},{"issue":"32","key":"10.1016\/j.neuint.2012.12.016_b0420","doi-asserted-by":"crossref","first-page":"11364","DOI":"10.1073\/pnas.0802076105","article-title":"Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress","volume":"105","author":"Gautier","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0425","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12031-010-9378-1","article-title":"Alpha-Synuclein transgenic mice reveal compensatory increases in Parkinson\u2019s disease-associated proteins DJ-1 and parkin and have enhanced alpha-synuclein and PINK1 levels after rotenone treatment","volume":"42","author":"George","year":"2010","journal-title":"J. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0430","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b0435","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1471-4159.1994.63030793.x","article-title":"Altered brain metabolism of iron as a cause of neurodegenerative diseases?","volume":"63","author":"Gerlach","year":"1994","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.neuint.2012.12.016_b0440","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0891-5849(02)00804-3","article-title":"The relationship between oxidative\/nitrative stress and pathological inclusions in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"32","author":"Giasson","year":"2002","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.neuint.2012.12.016_b0445","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/j.1471-4159.2009.06235.x","article-title":"Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability\u2013a point of convergence in parkinsonian neurodegeneration?","volume":"110","author":"Gillardon","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2012.12.016_b0450","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuroscience.2012.02.001","article-title":"Parkinson\u2019s disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity","volume":"208","author":"Gillardon","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2012.12.016_b0455","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-7091-6842-4_7","article-title":"Mechanism of 6-hydroxydopamine neurotoxicity","volume":"50","author":"Glinka","year":"1997","journal-title":"J. Neural. Transm."},{"issue":"10","key":"10.1016\/j.neuint.2012.12.016_b0460","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1096\/fj.05-3776fje","article-title":"Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system","volume":"19","author":"Godbout","year":"2005","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.neuint.2012.12.016_b0465","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1073\/pnas.0737556100","article-title":"Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants","volume":"100","author":"Greene","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0470","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","article-title":"Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin","volume":"23","author":"Greggio","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.neuint.2012.12.016_b0475","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s11064-010-0176-5","article-title":"Involvement of nitric oxide in maneb- and paraquat-induced Parkinson\u2019s disease phenotype in mouse: is there any link with lipid peroxidation?","volume":"35","author":"Gupta","year":"2010","journal-title":"Neurochem. Res."},{"issue":"7324","key":"10.1016\/j.neuint.2012.12.016_b0480","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nature09536","article-title":"Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1","volume":"468","author":"Guzman","year":"2010","journal-title":"Nature"},{"issue":"Pt 11","key":"10.1016\/j.neuint.2012.12.016_b0485","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1093\/brain\/awh584","article-title":"Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson\u2019s disease","volume":"128","author":"Halliday","year":"2005","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0490","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10059-011-0030-x","article-title":"RAGE: the beneficial and deleterious effects by diverse mechanisms of actions","volume":"31","author":"Han","year":"2011","journal-title":"Mol. Cells"},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0500","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/archneur.64.4.576","article-title":"Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease","volume":"64","author":"Hancock","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2012.12.016_b0495","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2377-8-6","article-title":"Pesticide exposure and risk of Parkinson\u2019s disease: a family-based case-control study","volume":"8","author":"Hancock","year":"2008","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.neuint.2012.12.016_b0510","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1073\/pnas.0705363105","article-title":"Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP","volume":"105","author":"Haque","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"27","key":"10.1016\/j.neuint.2012.12.016_b0505","doi-asserted-by":"crossref","first-page":"23162","DOI":"10.1074\/jbc.M112.346437","article-title":"Inactivation of Pink1 gene in vivo sensitizes dopamine-producing neurons to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and can be rescued by autosomal recessive Parkinson disease genes, Parkin or DJ-1","volume":"287","author":"Haque","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0515","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/mds.21766","article-title":"Parkinson\u2019s disease and aging: same or different process?","volume":"23","author":"Hawkes","year":"2008","journal-title":"Mov. Disord."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2012.12.016_b0520","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0006-8993(01)02681-6","article-title":"Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum","volume":"909","author":"He","year":"2001","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.neuint.2012.12.016_b0525","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0530","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.yexcr.2009.09.014","article-title":"LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity","volume":"316","author":"Heo","year":"2010","journal-title":"Exp. Cell Res."},{"issue":"7","key":"10.1016\/j.neuint.2012.12.016_b0535","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1212\/01.wnl.0000204446.82823.28","article-title":"Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease","volume":"66","author":"Hernan","year":"2006","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0540","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/nbdi.2000.0289","article-title":"The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system","volume":"7","author":"Herrera","year":"2000","journal-title":"Neurobiol. Dis."},{"issue":"12","key":"10.1016\/j.neuint.2012.12.016_b1370","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1523\/JNEUROSCI.16-12-03807.1996","article-title":"[3H]dihydrorotenone binding to NADH: ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study","volume":"16","author":"Higgins","year":"1996","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0545","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2012.12.016_b1325","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.parkreldis.2004.10.013","article-title":"Neuroinflammatory processes in Parkinson\u2019s disease","volume":"11","author":"Hirsch","year":"2005","journal-title":"Parkinsonism & related disorders"},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2012.12.016_b0555","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"issue":"8\u20139","key":"10.1016\/j.neuint.2012.12.016_b0560","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/BF01291789","article-title":"Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson\u2019s disease","volume":"103","author":"Hunot","year":"1996","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0565","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","article-title":"Nitric oxide synthase and neuronal vulnerability in Parkinson\u2019s disease","volume":"72","author":"Hunot","year":"1996","journal-title":"Neuroscience"},{"issue":"14","key":"10.1016\/j.neuint.2012.12.016_b0570","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","article-title":"Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease","volume":"94","author":"Hunot","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.neuint.2012.12.016_b0575","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999","article-title":"FcepsilonRII\/CD23 is expressed in Parkinson\u2019s disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells","volume":"19","author":"Hunot","year":"1999","journal-title":"J. Neurosci."},{"issue":"32","key":"10.1016\/j.neuint.2012.12.016_b0585","doi-asserted-by":"crossref","first-page":"28572","DOI":"10.1074\/jbc.M200666200","article-title":"Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome","volume":"277","author":"Hyun","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0580","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jnr.20638","article-title":"Effect of overexpression of wild-type or mutant parkin on the cellular response induced by toxic insults","volume":"82","author":"Hyun","year":"2005","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0590","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0595","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1460-9568.2005.04220.x","article-title":"The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation","volume":"22","author":"Iravani","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0600","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neulet.2012.01.022","article-title":"Lipopolysaccharide-induced nigral inflammation leads to increased IL-1beta tissue content and expression of astrocytic glial cell line-derived neurotrophic factor","volume":"510","author":"Iravani","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"19","key":"10.1016\/j.neuint.2012.12.016_b0605","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1093\/hmg\/ddq288","article-title":"Loss of the Parkinson\u2019s disease-linked gene DJ-1 perturbs mitochondrial dynamics","volume":"19","author":"Irrcher","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"18","key":"10.1016\/j.neuint.2012.12.016_b0615","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/hmg\/ddg239","article-title":"Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse","volume":"12","author":"Itier","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.neuint.2012.12.016_b0620","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2165\/00023210-200721080-00005","article-title":"Medical management of levodopa-associated motor complications in patients with Parkinson\u2019s disease","volume":"21","author":"Jankovic","year":"2007","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b0625","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0024-3205(85)90062-1","article-title":"Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects","volume":"36","author":"Johannessen","year":"1985","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b0630","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0304-3940(02)00016-2","article-title":"Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine","volume":"320","author":"Junn","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.neuint.2012.12.016_b0635","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.freeradbiomed.2009.08.003","article-title":"DJ-1 and prevention of oxidative stress in Parkinson\u2019s disease and other age-related disorders","volume":"47","author":"Kahle","year":"2009","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.08.041","article-title":"Chemokines in the MPTP model of Parkinson\u2019s disease: absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration","volume":"1128","author":"Kalkonde","year":"2007","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0645","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/aje\/kwk024","article-title":"Pesticide exposure and self-reported Parkinson\u2019s disease in the agricultural health study","volume":"165","author":"Kamel","year":"2007","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b0650","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1471-4159.1992.tb08350.x","article-title":"Is the vulnerability of neurons in the substantia nigra of patients with Parkinson\u2019s disease related to their neuromelanin content?","volume":"59","author":"Kastner","year":"1992","journal-title":"J. Neurochem."},{"issue":"14","key":"10.1016\/j.neuint.2012.12.016_b0660","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.0501282102","article-title":"Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress","volume":"102","author":"Kim","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0655","doi-asserted-by":"crossref","first-page":"e34693","DOI":"10.1371\/journal.pone.0034693","article-title":"Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0665","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1006\/mcne.2000.0914","article-title":"Inflammatory regulators in Parkinson\u2019s disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2","volume":"16","author":"Knott","year":"2000","journal-title":"Mol. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b0670","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","article-title":"Microglial and astrocytic involvement in a murine model of Parkinson\u2019s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"39","author":"Kohutnicka","year":"1998","journal-title":"Immunopharmacology"},{"issue":"22","key":"10.1016\/j.neuint.2012.12.016_b0675","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1111\/j.1742-4658.2009.07344.x","article-title":"LRRK2 in Parkinson\u2019s disease: genetic and clinical studies from patients","volume":"276","author":"Kumari","year":"2009","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0680","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0006-8993(01)03149-3","article-title":"6-Hydroxydopamine-lesioning of the nigrostriatal pathway in rats alters basal ganglia mRNA for copper, zinc- and manganese-superoxide dismutase, but not glutathione peroxidase","volume":"922","author":"Kunikowska","year":"2001","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55782\/ane-1999-1289","article-title":"MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson\u2019s disease","volume":"59","author":"Kurkowska Jastrzebska","year":"1999","journal-title":"Acta Neurobiol. Exp."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0690","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/exnr.1998.6993","article-title":"The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse","volume":"156","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0695","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","article-title":"Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain","volume":"39","author":"Lawson","year":"1990","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0700","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.stem.2010.11.028","article-title":"Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K\/Akt-dependant manner","volume":"8","author":"Le Belle","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0705","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11481-009-9176-0","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"4","author":"Lee","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0710","doi-asserted-by":"crossref","first-page":"e29935","DOI":"10.1371\/journal.pone.0029935","article-title":"Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation","volume":"7","author":"Lee","year":"2012","journal-title":"PLoS One"},{"issue":"9680","key":"10.1016\/j.neuint.2012.12.016_b0715","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson\u2019s disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.neuint.2012.12.016_b0730","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nn.2349","article-title":"Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson\u2019s disease","volume":"12","author":"Li","year":"2009","journal-title":"Nat. Neurosci."},{"issue":"38","key":"10.1016\/j.neuint.2012.12.016_b0720","doi-asserted-by":"crossref","first-page":"29569","DOI":"10.1074\/jbc.M110.127639","article-title":"Reevaluation of phosphorylation sites in the Parkinson disease-associated leucine-rich repeat kinase 2","volume":"285","author":"Li","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.neuint.2012.12.016_b0725","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1523\/JNEUROSCI.5604-09.2010","article-title":"Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson\u2019s disease mutation G2019S","volume":"30","author":"Li","year":"2010","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.neuint.2012.12.016_b0735","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0740","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuron.2009.11.006","article-title":"Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson\u2019s-disease-related mutant alpha-synuclein","volume":"64","author":"Lin","year":"2009","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0750","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/taap.1996.0054","article-title":"Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies","volume":"137","author":"Liou","year":"1996","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0745","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nbd.2008.06.016","article-title":"Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway","volume":"32","author":"Liou","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0755","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pneurobio.2011.06.005","article-title":"L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson\u2019s disease?","volume":"94","author":"Lipski","year":"2012","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0760","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000320027","article-title":"MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain","volume":"18","author":"Lofrumento","year":"2011","journal-title":"Neuroimmunomodulation"},{"issue":"7","key":"10.1016\/j.neuint.2012.12.016_b0765","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1523\/JNEUROSCI.5351-08.2009","article-title":"Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein","volume":"29","author":"Lu","year":"2009","journal-title":"J. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2012.12.016_b0780","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.physbeh.2009.04.021","article-title":"Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson\u2019s disease","volume":"98","author":"Luchtman","year":"2009","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0775","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbr.2011.09.033","article-title":"Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson\u2019s disease","volume":"226","author":"Luchtman","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"21","key":"10.1016\/j.neuint.2012.12.016_b0785","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson\u2019s disease and mutations in the parkin gene","volume":"342","author":"Lucking","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0790","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neuron.2006.10.008","article-title":"The familial Parkinsonism gene LRRK2 regulates neurite process morphology","volume":"52","author":"MacLeod","year":"2006","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.neuint.2012.12.016_b0795","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.neurobiolaging.2011.02.016","article-title":"Interferon-gamma plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways","volume":"33","author":"Mangano","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0800","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2007.03.014","article-title":"Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter","volume":"27","author":"Manning-Bog","year":"2007","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0815","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1523\/JNEUROSCI.4308-05.2006","article-title":"Parkinson\u2019s disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death","volume":"26","author":"Martin","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2012.12.016_b0810","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0079-6123(10)83002-X","article-title":"The impact of genetic research on our understanding of Parkinson\u2019s disease","volume":"183","author":"Martin","year":"2011","journal-title":"Prog. Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2012.12.016_b1330","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2003.12.034","article-title":"The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro","volume":"2004","author":"Mazzio","year":"2004","journal-title":"Brain Res."},{"issue":"37","key":"10.1016\/j.neuint.2012.12.016_b0825","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","article-title":"Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson\u2019s disease","volume":"26","author":"McCoy","year":"2006","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.neuint.2012.12.016_b0830","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0835","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/exnr.2001.7688","article-title":"Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons","volume":"169","author":"McGuire","year":"2001","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0840","first-page":"58","article-title":"Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye","volume":"29","author":"Medawar","year":"1948","journal-title":"Br. J. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b0845","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nbd.2010.07.010","article-title":"Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice","volume":"40","author":"Melrose","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0850","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.expneurol.2009.06.005","article-title":"Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson\u2019s disease","volume":"219","author":"Meredith","year":"2009","journal-title":"Exp. Neurol."},{"issue":"17","key":"10.1016\/j.neuint.2012.12.016_b0855","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.cub.2005.07.064","article-title":"Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson\u2019s disease","volume":"15","author":"Meulener","year":"2005","journal-title":"Curr. Biol."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0860","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","article-title":"Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys","volume":"197","author":"Miklossy","year":"2006","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.neuint.2012.12.016_b0865","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","article-title":"LRRK2 inhibition attenuates microglial inflammatory responses","volume":"32","author":"Moehle","year":"2012","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0870","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2012.12.016_b0895","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0875","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02252965","article-title":"Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson\u2019s disease","volume":"9","author":"Mogi","year":"1995","journal-title":"J. Neural. Transm. Park Dis. Dement Sect."},{"issue":"8\u20139","key":"10.1016\/j.neuint.2012.12.016_b0880","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/BF01291792","article-title":"Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain. Short communication","volume":"103","author":"Mogi","year":"1996","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0885","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","article-title":"Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson\u2019s disease","volume":"211","author":"Mogi","year":"1996","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b0910","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3940(00)01275-1","article-title":"Increase in level of tumor necrosis factor-alpha in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosuppressant FK506","volume":"289","author":"Mogi","year":"2000","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0905","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","article-title":"P53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain","volume":"414","author":"Mogi","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2012.12.016_b0915","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson\u2019s disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"issue":"22","key":"10.1016\/j.neuint.2012.12.016_b0920","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e3181ff9685","article-title":"Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2","volume":"75","author":"Mortiboys","year":"2010","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.neuint.2012.12.016_b0925","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","article-title":"Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons","volume":"27","author":"Mount","year":"2007","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.neuint.2012.12.016_b0930","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/s11064-011-0471-9","article-title":"Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson\u2019s disease brains","volume":"36","author":"Mythri","year":"2011","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.neuint.2012.12.016_b0935","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1083\/jcb.200809125","article-title":"Parkin is recruited selectively to impaired mitochondria and promotes their autophagy","volume":"183","author":"Narendra","year":"2008","journal-title":"J. Cell. Biol."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b0940","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.stem.2011.01.013","article-title":"LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress","volume":"8","author":"Nguyen","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0945","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.neurobiolaging.2005.04.010","article-title":"Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice","volume":"27","author":"Nieto","year":"2006","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b1345","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1471-4159.2012.07809.x","article-title":"Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via dynamin-like protein","volume":"122","author":"Niu","year":"2012","journal-title":"J. Neurochem."},{"issue":"Suppl. 1","key":"10.1016\/j.neuint.2012.12.016_b1375","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1017\/S0317167100046333","article-title":"Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson\u2019s disease","volume":"11","author":"Langston","year":"1984","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b0955","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson\u2019s disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b0960","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0006-8993(94)90833-8","article-title":"Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study","volume":"660","author":"Oestreicher","year":"1994","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0965","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","article-title":"Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease","volume":"44","author":"Paisan-Ruiz","year":"2004","journal-title":"Neuron"},{"issue":"18","key":"10.1016\/j.neuint.2012.12.016_b0970","doi-asserted-by":"crossref","first-page":"18614","DOI":"10.1074\/jbc.M401135200","article-title":"Mitochondrial dysfunction and oxidative damage in parkin-deficient mice","volume":"279","author":"Palacino","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.neuint.2012.12.016_b0980","doi-asserted-by":"crossref","first-page":"13971","DOI":"10.1523\/JNEUROSCI.3799-09.2009","article-title":"Phosphorylation of ezrin\/radixin\/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis","volume":"29","author":"Parisiadou","year":"2009","journal-title":"J. Neurosci."},{"issue":"7097","key":"10.1016\/j.neuint.2012.12.016_b0985","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nature04788","article-title":"Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin","volume":"441","author":"Park","year":"2006","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b0990","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/sj.mt.6300067","article-title":"DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice","volume":"15","author":"Paterna","year":"2007","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b0995","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuroscience.2006.12.030","article-title":"Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson\u2019s disease","volume":"145","author":"Pattarini","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2012.12.016_b1000","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2202-6-71","article-title":"Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity","volume":"6","author":"Perez","year":"2005","journal-title":"BMC Neurosci."},{"issue":"5","key":"10.1016\/j.neuint.2012.12.016_b1010","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1471-4159.2005.03442.x","article-title":"Proteomic analysis of parkin knockout mice. alterations in energy metabolism, protein handling and synaptic function","volume":"95","author":"Periquet","year":"2005","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.neuint.2012.12.016_b1015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0361-9230(92)90142-K","article-title":"Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain","volume":"29","author":"Perumal","year":"1992","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b1380","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"7","author":"Perry","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"40","key":"10.1016\/j.neuint.2012.12.016_b1020","doi-asserted-by":"crossref","first-page":"34025","DOI":"10.1074\/jbc.M505143200","article-title":"Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations","volume":"280","author":"Petit","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b1025","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1471-4159.2008.05217.x","article-title":"Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells","volume":"105","author":"Plowey","year":"2008","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b1030","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nbd.2004.12.009","article-title":"Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice\u2014a model of familial Parkinson\u2019s disease","volume":"18","author":"Poon","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"Pt 7","key":"10.1016\/j.neuint.2012.12.016_b1335","first-page":"1880","article-title":"Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson\u2019s disease","volume":"131","author":"Pott Godoy","year":"2008","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b1385","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2006.10.008","article-title":"Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration","volume":"25","author":"Purisai","year":"2007","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b1040","doi-asserted-by":"crossref","first-page":"e18568","DOI":"10.1371\/journal.pone.0018568","article-title":"Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2","volume":"6","author":"Ramonet","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b1045","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1046\/j.1471-4159.2001.00366.x","article-title":"Sensitivity to MPTP is not increased in Parkinson\u2019s disease-associated mutant alpha-synuclein transgenic mice","volume":"77","author":"Rathke-Hartlieb","year":"2001","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b1050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0404.2011.01528.x","article-title":"Alterations of T cell subsets in ALS: a systemic immune activation?","volume":"125","author":"Rentzos","year":"2012","journal-title":"Acta Neurol. Scand."},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b1055","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/j.1471-4159.2007.05087.x","article-title":"Nitrated alpha-synuclein-activated microglial profiling for Parkinson\u2019s disease","volume":"104","author":"Reynolds","year":"2008","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b1060","first-page":"744","article-title":"Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain","volume":"249","author":"Riachi","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b1065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1471-4159.2007.04762.x","article-title":"Mortality, oxidative stress and tau accumulation during ageing in parkin null mice","volume":"103","author":"Rodriguez-Navarro","year":"2007","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.neuint.2012.12.016_b1075","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","article-title":"Initial clinical manifestations of Parkinson\u2019s disease: features and pathophysiological mechanisms","volume":"8","author":"Rodriguez-Oroz","year":"2009","journal-title":"Lancet Neurol."},{"issue":"5B","key":"10.1016\/j.neuint.2012.12.016_b1340","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/j.1582-4934.2008.00450.x","article-title":"Immunological features of alpha-synuclein in Parkinson\u2019s disease","volume":"12","author":"Roodveldt","year":"2008","journal-title":"J. Cell. Mol. Med."},{"issue":"39","key":"10.1016\/j.neuint.2012.12.016_b1085","doi-asserted-by":"crossref","first-page":"15918","DOI":"10.1073\/pnas.1205102109","article-title":"Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease","volume":"109","author":"Rousseaux","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"29","key":"10.1016\/j.neuint.2012.12.016_b1090","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1523\/JNEUROSCI.2281-09.2009","article-title":"LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans","volume":"29","author":"Saha","year":"2009","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b1095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-1-6","article-title":"Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson\u2019s disease","volume":"1","author":"Sanchez-Pernaute","year":"2004","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.neuint.2012.12.016_b1100","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1523\/JNEUROSCI.4810-06.2007","article-title":"A Drosophila model of mutant human parkin-induced toxicity demonstrates selective loss of dopaminergic neurons and dependence on cellular dopamine","volume":"27","author":"Sang","year":"2007","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b1105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12640-009-9061-x","article-title":"Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson\u2019s disease","volume":"16","author":"Schintu","year":"2009","journal-title":"Neurotox. Res."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b1110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(03)00172-1","article-title":"Selective microglial activation in the rat rotenone model of Parkinson\u2019s disease","volume":"341","author":"Sherer","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"34","key":"10.1016\/j.neuint.2012.12.016_b1115","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson\u2019s disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b1120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/exnr.2002.8072","article-title":"Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation","volume":"179","author":"Sherer","year":"2003","journal-title":"Exp. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2012.12.016_b1125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(01)02577-X","article-title":"Carrier-mediated processes in blood\u2013brain barrier penetration and neural uptake of paraquat","volume":"906","author":"Shimizu","year":"2001","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b1130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/77060","article-title":"Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase","volume":"25","author":"Shimura","year":"2000","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.neuint.2012.12.016_b1350","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1373\/clinchem.2012.187054","article-title":"Parkin and parkinson disease","volume":"58","author":"Shimura","year":"2012","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b1140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson\u2019s disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"10","key":"10.1016\/j.neuint.2012.12.016_b1150","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nn1776","article-title":"Kinase activity of mutant LRRK2 mediates neuronal toxicity","volume":"9","author":"Smith","year":"2006","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b1155","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1523\/JNEUROSCI.4609-07.2008","article-title":"Glial dysfunction in parkin null mice. Effects of aging","volume":"28","author":"Solano","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b1160","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0014-4886(03)00342-X","article-title":"Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP","volume":"186","author":"Song","year":"2004","journal-title":"Exp. Neurol."},{"issue":"6645","key":"10.1016\/j.neuint.2012.12.016_b1165","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b1170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.2042-7158.1997.tb06761.x","article-title":"Nitric oxide scavenging by curcuminoids","volume":"49","author":"Sreejayan","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"issue":"11","key":"10.1016\/j.neuint.2012.12.016_b1175","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1096\/fj.02-0216fje","article-title":"Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson\u2019s disease","volume":"16","author":"Sriram","year":"2002","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b1180","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b1185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","article-title":"Neuroinflammatory mechanisms in Parkinson\u2019s disease: potential environmental triggers, pathways, and targets for early therapeutic intervention","volume":"208","author":"Tansey","year":"2007","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b1190","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0006-8993(00)02496-3","article-title":"Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson\u2019s disease?","volume":"873","author":"Thiruchelvam","year":"2000","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b1195","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/hmg\/ddq430","article-title":"DJ-1 acts in parallel to the PINK1\/parkin pathway to control mitochondrial function and autophagy","volume":"20","author":"Thomas","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"21","key":"10.1016\/j.neuint.2012.12.016_b1200","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1073\/pnas.1004676107","article-title":"Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice","volume":"107","author":"Tong","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.neuint.2012.12.016_b1205","doi-asserted-by":"crossref","first-page":"e23660","DOI":"10.1371\/journal.pone.0023660","article-title":"Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B","volume":"6","author":"Tran","year":"2011","journal-title":"PLoS One"},{"issue":"5674","key":"10.1016\/j.neuint.2012.12.016_b1210","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuint.2012.12.016_b1215","doi-asserted-by":"crossref","first-page":"624925","DOI":"10.1155\/2012\/624925","article-title":"Oxidative stress in genetic mouse models of Parkinson\u2019s disease","volume":"2012","author":"Varcin","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"22","key":"10.1016\/j.neuint.2012.12.016_b1220","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1093\/hmg\/ddp394","article-title":"Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson\u2019s disease","volume":"18","author":"Venderova","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.neuint.2012.12.016_b1225","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1096\/fj.08-125153","article-title":"Regulation of astrocyte inflammatory responses by the Parkinson\u2019s disease-associated gene DJ-1","volume":"23","author":"Waak","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.neuint.2012.12.016_b1230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1326-3-3","article-title":"Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons","volume":"3","author":"Wang","year":"2008","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b1235","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.expneurol.2012.06.025","article-title":"Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein","volume":"237","author":"Watson","year":"2012","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b1240","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/hmg\/ddl471","article-title":"Parkinson\u2019s disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity","volume":"16","author":"West","year":"2007","journal-title":"Hum. Mol. Genet."},{"issue":"22","key":"10.1016\/j.neuint.2012.12.016_b1245","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1073\/pnas.0501078102","article-title":"Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson\u2019s disease","volume":"102","author":"Whitworth","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b1250","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jocn.2004.10.002","article-title":"Autotoxicity, methylation and a road to the prevention of Parkinson\u2019s disease","volume":"12","author":"Williams","year":"2005","journal-title":"J. Clin.Neurosci."},{"key":"10.1016\/j.neuint.2012.12.016_b1255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1326-2-10","article-title":"Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient mice","volume":"2","author":"Yamaguchi","year":"2007","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.neuint.2012.12.016_b1265","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.10709","article-title":"Minocycline enhances MPTP toxicity to dopaminergic neurons","volume":"74","author":"Yang","year":"2003","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.neuint.2012.12.016_b1355","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2012.05.020","article-title":"LRRK2 kinase activity mediates toxic interactions between genetic mutation and oxidative stress in a Drosophila model: suppression by curcumin","volume":"47","author":"Yang","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b1270","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nbd.2010.04.002","article-title":"LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson\u2019s disease","volume":"40","author":"Yao","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2012.12.016_b1275","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.brainres.2006.12.054","article-title":"Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"1138","author":"Yasuda","year":"2007","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.neuint.2012.12.016_b1280","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/mds.23737","article-title":"Genetic LRRK2 models of Parkinson\u2019s disease: Dissecting the pathogenic pathway and exploring clinical applications","volume":"26","author":"Yue","year":"2011","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.neuint.2012.12.016_b1290","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.neuint.2012.12.016_b1285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12640-009-9140-z","article-title":"Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson\u2019s disease","volume":"19","author":"Zhang","year":"2011","journal-title":"Neurotox. Res."},{"issue":"12","key":"10.1016\/j.neuint.2012.12.016_b1295","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1038\/sj.npp.1301381","article-title":"Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation","volume":"32","author":"Zhou","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.neuint.2012.12.016_b1300","first-page":"1180","article-title":"Early exposure to paraquat sensitizes dopaminergic neurons to subsequent silencing of PINK1 gene expression in mice","volume":"7","author":"Zhou","year":"2011","journal-title":"J. Biol. Sci."},{"issue":"7","key":"10.1016\/j.neuint.2012.12.016_b1305","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/j.1460-9568.2007.05812.x","article-title":"Non-motor behavioural impairments in parkin-deficient mice","volume":"26","author":"Zhu","year":"2007","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.neuint.2012.12.016_b1310","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018612004147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018612004147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T07:48:14Z","timestamp":1714808894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018612004147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":255,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0197018612004147"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2012.12.016","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}